Article
Update on gut microbiota in gastrointestinal diseases
22 Jul 2022
Abstract excerpt
infection (CDI). These findings have led to the development of treatments targeting the gut microbiota, such as probiotics and FMT for inflammatory bowel diseases (IBD) and other diseases. This review focuses on the association of the gut microbiota with human gastrointestinal diseases, including CDI, IBD, and irritable bowel syndrome. We also summarize the therapeutic options for targeting the altered gut...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
